Skip to main content

Table 1 Response of behavioral symptoms and renal angiomyolipomas to everolimus treatment

From: Everolimus improves behavioral deficits in a patient with autism associated with tuberous sclerosis: a case report

 

Baseline

6 months

18 months

% improvement a

PARS-infant score (0-68)

28

   

PARS-present score (0-66)

39

32

21

46.15%

ABC Irritability score (0-45)

33

9

0

100%

ABC lethargy/social withdrawal score (0-48)

27

25

19

29.62%

ABC stereotypic behavior score (0-21)

12

0

2

83.33%

ABC hyperactivity score (0-48)

18

15

14

22.22%

ABC inappropriate Speech score (0-12)

2

1

0

100%

AML volume

5.58

4.68

4.06

27.2%

  1. aRelative to baseline. PARS, Pervasive Developmental Disorders - Autism Society Japan Rating Scale; ABC, the Aberrant Behavior Checklist; AML, angiomyolipoma.